SSKN — STRATA Skin Sciences Share News
0.000.00%
- $0.00m
- $7.44m
- $30.70m
Brief: Strata Skin Sciences Inc Files For Mixed Shelf Of Up To $25 Million - SEC Filing
Strata Skin Sciences Inc Reports Results For The Quarter Ended September 30: Earnings Summary
Brief: Strata Skin Sciences Designated John Gillings, As Principal Financial Officer And Principal Accounting Officer
Strata Skin Sciences Inc Expected To Post A Loss Of 44 Cents A Share: Earnings Preview
Brief: Strata Skin Sciences Files Complaint Against Laseroptek, Monarch Laser Services, And The Pinnacle Health Group
Strata Skin Sciences Inc Reports Results For The Quarter Ended In June: Earnings Summary
Strata Skin Sciences Inc Expected To Post A Loss Of 70 Cents A Share: Earnings Preview
Brief: Strata Skin Sciences Completes $2.1 Mln Direct Offering With Participation From Insiders
Brief: Strata Skin Sciences Gets Japan Approval For Xtrac Momentum 1.0 Device
Brief: STRATA Skin Sciences’ TheraClear®X Acne Therapy System Found to be Safe and Effective for Acne Lesions Across All Fitzpatrick Skin Types
Strata Skin Sciences Inc Reports Results For The Quarter Ended In March: Earnings Summary
Brief: STRATA Skin Sciences Q1 Net Income USD -3.4 Million
Strata Skin Sciences Inc Expected To Post A Loss Of 7 Cents A Share: Earnings Preview
Brief: Strata Skin Sciences Announces XTRAC Comeback Placements In Q1 Of 2024
Brief: STRATA Skin Sciences Announces Renewal Of Exclusive Distribution Agreements In China, Japan
Strata Skin Sciences Inc Reports Results For The Quarter Ended In December: Earnings Summary
Brief: STRATA Skin Sciences Q4 Net Income USD -3.8 Million
Strata Skin Sciences Inc Expected To Post A Loss Of 2 Cents A Share: Earnings Preview
Brief: STRATA Skin Sciences Announces Initiative to Expand Treatment Coverage